Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

1.76
-0.1200-6.38%
Post-market: 1.790.0300+1.70%19:55 EDT
Volume:133.33K
Turnover:233.60K
Market Cap:2.89M
PE:-0.15
High:1.82
Open:1.80
Low:1.71
Close:1.88
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 31, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 13, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 05, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 01, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 18, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 17, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 14, 2022

Major Issues Report

8-K - Current report